November 27, 2019     Cenobamate FDA-Approved for Partial-Onset Seizures The FDA has granted approval to cenobamate (Xcopri, SK Life Science) for the treatment of partial-onset seizures in adults. Read more ADVERTISEMENT   Diroximel Fumarate Is Approved for Relapsing Forms of MS, Clinically Isolated Syndrome Biogen and Alkermes have announced that the FDA has approved their multiple sclerosis (MS) agent diroximel fumarate (Vumerity) for the treatment of relapsing forms of MS, including relapsing-remitting and secondary progressive disease, as well as clinically isolated syndrome (CIS). Read more